These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18066478)

  • 1. [External quality control in cervical cytopathology: an evaluation from 2000-2004].
    Rev Saude Publica; 2007 Dec; 41(6):1071. PubMed ID: 18066478
    [No Abstract]   [Full Text] [Related]  

  • 2. Random rescreening of cytologic smears: a practical and effective component of quality assurance programs in both large and small cytology laboratories.
    Krieger P; Naryshkin S
    Acta Cytol; 1994; 38(3):291-8. PubMed ID: 8191815
    [No Abstract]   [Full Text] [Related]  

  • 3. Replies to questions on Quality Assurance Measures in Cytopathology.
    Acta Cytol; 1989; 33(4):559-61. PubMed ID: 2750444
    [No Abstract]   [Full Text] [Related]  

  • 4. The challenge of quality improvement with the Papanicolaou smear.
    Kline TS
    Arch Pathol Lab Med; 1997 Mar; 121(3):253-5. PubMed ID: 9111111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society for Cytotechnology quality assurance survey data. Summary report.
    Ashton PR
    Acta Cytol; 1989; 33(4):451-4. PubMed ID: 2750434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly rescreening of 10% of the total cervical Papanicolaou smears: a worthwhile quality assurance scheme.
    Sampatanukul P; Wannakrairot P; Promprakob U; Yodavudh S; Anansiriprapa C
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S261-5. PubMed ID: 16083199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cervical screening--its essence and quality-control methodology in cytology laboratories].
    Kostova P
    Akush Ginekol (Sofiia); 1998; 37(4):58-61. PubMed ID: 10360060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of working party on internal quality control for cervical cytopathology laboratories summary and recommendations.
    Cytopathology; 1996 Feb; 7(1):4-9. PubMed ID: 8833868
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality assurance in cervical cytopathology.
    Llewellyn H
    Cytopathology; 1997 Oct; 8(5):349-50; author reply 353-4. PubMed ID: 9313988
    [No Abstract]   [Full Text] [Related]  

  • 10. Quality assurance in cervical cytopathology.
    Coleman DV; Baker R
    Cytopathology; 1997 Oct; 8(5):350-3; author reply 353-4. PubMed ID: 9313989
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality assurance in cervical cytopathology--time for a more evidence-based approach.
    Slater DN
    Cytopathology; 1997 Apr; 8(2):75-8. PubMed ID: 9134331
    [No Abstract]   [Full Text] [Related]  

  • 12. Technical proficiency in cytopathology: assessment through external quality assurance.
    Cummings MC; Greaves J; Shukor RA; Perkins G; Ross J
    Cytopathology; 2017 Apr; 28(2):149-156. PubMed ID: 27678252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In-house quality assurance program in a state cytology laboratory.
    Gardner NM
    Acta Cytol; 1989; 33(4):487-8. PubMed ID: 2750439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using urbanization profiles to assess screening performance.
    Boon ME; Kok LP
    Diagn Cytopathol; 2004 Apr; 30(4):243-6. PubMed ID: 15048958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance measures for Australian laboratories reporting cervical cytology: a decade of data 1998-2008.
    Shield PW; Finnimore J; Cummings M; Wright RG
    Pathology; 2010 Dec; 42(7):623-8. PubMed ID: 21080870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cervical smears and evaluation of quality].
    Marsan C
    Ann Pathol; 1996 Nov; 16(5):344-9. PubMed ID: 9004721
    [No Abstract]   [Full Text] [Related]  

  • 17. When MTs mind the Paps: QA for send-out tests.
    Cruzvergara M
    MLO Med Lab Obs; 1991 Feb; 23(2):31-5. PubMed ID: 10109603
    [No Abstract]   [Full Text] [Related]  

  • 18. External quality control for cytopathology--a pilot scheme.
    Brown BE; Chapman PA
    Med Lab Sci; 1976 Jul; 33(3):215-9. PubMed ID: 1011949
    [No Abstract]   [Full Text] [Related]  

  • 19. Companies build Pap smear safety nets.
    Scott L
    Mod Healthc; 1995 May; 25(19):70. PubMed ID: 10142267
    [No Abstract]   [Full Text] [Related]  

  • 20. Pap smear concerns.
    Moran T
    Tex Med; 1997 Nov; 93(11):44-6. PubMed ID: 9369088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.